Systemic immune-inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration-resistant prostate cancer patients
2019 ◽
Vol 51
(12)
◽
pp. 2189-2199
◽
2011 ◽
2013 ◽